KRAS and gastrointestinal stromal tumor: The series consisted of 26 GIST specimens selected as negative for KIT/PDGFRA/BRAF/NRAS/KRAS mutations and with intact SDH complex, whose molecular characterization was performed by Sanger sequencing and immunohistochemistry.